Skip to main content

ASEAN Dysphagia Diet Thickening Agents Market 2022- Upcoming Trends, Growth Drivers to forecast year 2032

 With recorded sales worth of US$ 19.9 Mn in 2021, the ASEAN dysphagia diet thickening agents market is expected to experience high growth over the forecast period owing to rising ageing population and increasing number of swallowing disorders in the ASEAN region. The dysphagia diet thickening agents market is estimated to expand at a value CAGR of nearly 5.3% from 2022 to 2032.

Dysphagia is a disorder that makes it hard to swallow, owing to the loss of muscle control. It could be caused by many conditions and diseases that affect the muscles or nerves in the chest, head, abdomen, or neck.

The most common causes are Parkinson’s disease and stroke; however, it may also be caused from oral cancer surgery, brain injury (such as traumatic brain injury), or other medical conditions such as amyotrophic lateral sclerosis (ALS).

Get a Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/33043

In addition, dysphagia is one of the major side effects of smoking cigarettes for prolonged durations. In 2020, the highest prevalence of tobacco use in the world was reported in South East Asian region at 27.9%. It has been estimated by WHO that smoking kills around 6 Mn people each year.

The smoking rate for men in Asian countries is significantly higher at 35% than the OECD average of 24. This fuels dysphagia slowly through reduction in food consumption and leads to rising incidence of oropharyngeal cancer. Dysphagia is also prevalent among the elderly population.

Thus, rising prevalence of dysphagia and growing need for dysphagia diets in the elder population are boosting demand growth of dysphagia diet thickening agents. Furthermore, dysphagia treatment and awareness surrounding it has increased, owing to practical swallowing problems encountered by patients suffering from dysphagia, and this is projected to drive market growth going forward.

Company Profiles:

  • Brenntag Sdn. Bhd.
  • Deosen Biochemical (Ordos) Ltd.
  • R.T. Vanderbilt Holding Company, Inc.
  • Abbott
  • Nestlé Health Science (Nestlé)
  • Danone S.A.
  • Hormel Foods Corporation
  • Flavour Creations
  • Ingredion Incorporated
  • IFF Nutrition & Biosciences
  • Precise (Trisco Foods)
  • Produits Alimentaires Berthelet Inc.
  • CP Kelco U.S., Inc.
  • Slo Drinks Ltd
  • The Healthy Food Co., Ltd.
  • Kent Precision Foods Group, Inc.
  • Welltop Food Ingredients Sdn. Bhd.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33043

Key Takeaways from Market Study

  • Demand for powder thickeners by form type for dysphagia diet thickening agents is growing tremendously. The powder form is a readily available substitute for gel-type thickeners for the management of dysphagia in most cases, and the segment is expected to hold a market share of around 82.3% by value in 2022.
  • Hospital pharmacies are steadily growing because of the availability of adequate supply of broad variety of dysphagia diet thickening agents and well-skilled supported staff. Thus, hospital pharmacies will hold a high market share of 50.1% in 2022
  • The Indonesia dysphagia diet thickening agents market will account for around 22.6% market share in 2022.

“Increasing prevalence of strokes and swallowing disorders, rising awareness regarding dysphagia in ASEAN countries, and launching of paediatric-specific thickening products will boost the ASEAN dysphagia diet thickening agents market over the coming years,” says an analyst of Persistence Market Research.

Market Competition

Key market players promote their products at professional scientific meetings and conferences. This promotional strategy is expected to be highly impactful to enter the market.

Additionally, industry grouping (acquisitions or collaboration/partnership agreements) aims to support the distribution of a wide range of products across economies, and emerging players are extending their partnerships to strengthen their product portfolios.

  • For instance, in July 2020, Ingredion Incorporated acquired PureCircle Limited in order to strengthen its product portfolio.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/33043

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the ASEAN dysphagia diet thickening agents market in its latest study, presenting historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the form (gel type thickeners, powder thickeners) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), across the ASEAN region.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com


Top Market Insights

The Insulin Delivery Device Market To Show Constructive Disruption With US$ 14.09 Billion

Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices - Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a  CAGR of 7%  from 2014 to 2020, to reach an estimated value of  USD 14,093.3 million in 2020 . The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market. Get Going With Sample Of Insulin Delivery Device Market Report!  https://www.persistencemarketresearch.co/samples/2823 Some of the major players operating in the market: Abbott Laboratories. Novo Nordisk A/S. Eli Lilly and Company. Medtronic, Inc. Sanofi, Becton. Dickinson and Company...
Read Full Insight

The Bioinformatics Market To Grow Inadvertently

The Bioinformatics Market is bound to grow vigorously in the next 10 years. IoT has already made a beeline to the healthcare vertical. This has, in turn, enabled tracking of real-time locations of the apparatus and medical devices like scales, wheelchairs, defibrillators, or nebulizers along with remote monitoring. The entire healthcare vertical is expected to run on the IoT wave going forward.   The global  bioinformatics market  is exhibiting a  20.40% CAGR  from 2014 to 2020, according to a new market study recently released by Persistence Market Research. The market was calculated to be worth  US$4.1 bn  in 2014 and is estimated to reach  US$12.5 bn  by 2020, says PMR’s report, titled ‘ Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020 ’.   Get Going With Sample Of Bioinformatics Market Report!  https://www.persistencemarketresearch.com/samples/2778   The bioinformatics market is drive...
Read Full Insight

The Next 10 Years To Witness Formidable Growth Of Hospital Acquired Pneumonia Prevention Market (CAGR Of 4.7%) Between 2026

  The   Hospital Acquired Pneumonia Prevention Market Share   is estimated to be reaching   US$ 1,100 Million   at a   CAGR of 4.7%   from   2026 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global  hospital-acquired pneumonia prevention market . The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The  US$ 795 Mn  market is likely to exhibit a CAGR of 4.7%, reaching a value in exce...
Read Full Insight

The Next Decade To Sparkle With Acne Treatment Market Growing At The Rate Of 4.6% From 2025

  The   Acne Treatment Market Share   is estimated to be reaching   US$ 4,500 Million   at a   CAGR of 4.6%   from   2025 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication. Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate...
Read Full Insight

Opioids Market to Register CAGR 4.7% Increase in Revenue by 2021 End

  Persistence Market Research (PMR) delivers key insights on the Global   Opioids Market   in its latest report titled “Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast period (2015-2021). By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and methadone. Morphine segment was the largest contributor in overall opioids market, accounting for around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7% during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative growth opportunities in opioids market, owing to their potential application in opioid substitution treatment and fewer side effects as compared to natural opioids. Get Sample Copy of Report @  https://www.persis...
Read Full Insight

Geographical Expansion To Catalyze The HPMC Capsules Market (US$ 120 Million) From 2025

  The   Global HPMC Capsules Market Share  is expected to reach   US$ 120 Million   at a CAGR of   10.9%   between   2025 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study on the  global HPMC capsules market ...
Read Full Insight

The Peripheral Intravenous Catheter Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7% Between 2019 to 2029

The  Global Peripheral Intravenous Catheter Market Share  is expected to reach  US$ 4.9 Billion  at a CAGR of  7%  between  2019 to 2029 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 2020 – 2030 ). Strategizi...
Read Full Insight

The Perfusion Bioreactors Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7.5% Between 2021-2031

  The   Ischemic Optic Neuropathy Treatment Market Share  is expected to reach   US$ 187.7 Mn   at the rate of   3.7%   from   2021-2031 . With effective remote monitoring, the healthcare vertical is onto the awareness-building spree, so that patients could get benefited out of these services, telehealth, in particular. As such, several informative landing pages could be seen about the remote monitoring software. Ischemic optic neuropathy occurs because of a small vessel infraction of the optic nerve, and is a significant reason for impaired vision or blindness. Increasing utilization of newly approved intravitreal implants for the treatment of optic nerve disorders is expected to drive the market over the coming years. With developing awareness toward eye-associated inconveniences that give rise to impaired vision, diabetic patients and the geriatric population in developed nations are believed to have a proactive methodology for treatment-associ...
Read Full Insight

Sequential Advancements In Technology To Drive The Autogenous Vaccine For Aquaculture Market

  The   Autogenous Vaccine For Aquaculture Market Share  is expected to reach   US$ 11 Mn   between   2020 to 2030   at a   CAGR of 6% . Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward. Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish s...
Read Full Insight

Medical Tapes Market to Generate Lucrative Revenue Prospects for Manufacturers

  In a new report titled  ‘Medical Tapes Market: Global Industry Analysis and Forecast 2016 – 2024’,  Persistence Market Research analyzes the performance of the global  medical tapes market  over an eight-year period and provides insights on the key factors and trends likely to influence the market during the forecast period (2016 – 2024). The global medical tapes market is expected to register a  CAGR of 5.8%  during the forecast period 2016–2024. In this report, the global medical tapes market is tracked in terms of value and is calibrated to obtain market revenue estimates. Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/3435 Company Profile 3M Johnson & Johnson Paul Hartmann AG. Scapa Group PLC Andover Healthcare Inc. Ad Tape & Label Medtronic Get To Know Methodology of Report @  https://www.persistencemarketresearch.com/methodology/3435 Market dynamics Rising incidences of Healthcare Acquired Infec...
Read Full Insight